Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination

Clinical and Vaccine Immunology

Volumn 18, Issue 9, 2011, Pages 1519-1523

  Choi, Yoon Seok ^a   Baek, Yun Hee ^b   Kang, Wonseok ^a   Nam, Seung Joo ^a   Lee, Jino ^a   You, Sooseong ^a   Chang, Dong Yeop ^a   Youn, Jong Chan ^a,c   Choi, Young Ki ^b   Shin, Eui Cheol ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSPOT ASSAY; EPIDEMIC; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; KOREA; MEDICAL HISTORY; PRIORITY JOURNAL; SEASONAL INFLUENZA; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; SEASONS; TREATMENT OUTCOME; VACCINATION;

EID: 80052499666     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05053-11     Document Type: Article

References (21)

1. CDC. 2009. Announcement: national influenza vaccination week - January 12 to 16, 2010. MMWR Morb. Mortal. Wkly. Rep. 58:1444.
2. CDC. 2009. Swine influenza A (H1N1) infection in two children - Southern California, March- April 2009. MMWR Morb. Mortal. Wkly. Rep. 58:400-402.
3. CDC. 2009. Use of influenza A (H1N1) 2009 monovalent vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 58:1-8.
4. Clark, T. W., et al. 2009. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361:2424-2435.
5. Davenport, F. M., and A. V. Hennessy. 1957. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. Exp. Med. 106:835-850.
6. Davenport, F. M., and A. V. Hennessy. 1956. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. J. Exp. Med. 104:85-97.
7. Dawood, F. S., et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
8. Del Giudice, G., et al. 2009. Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci. Transl. Med. 1:12re1.
9. Ellebedy, A. H., et al. 2010. Contemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) virus vaccination in ferrets. Clin. Vaccine Immunol. 17:1998-2006.
10. Greenberg, M. E., et al. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361:2405-2413.
11. Hancock, K., et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
12. Kim, J. H., I. Skountzou, R. Compans, and J. Jacob. 2009. Original antigenic sin responses to influenza viruses. J. Immunol. 183:3294-3301.
13. Klenerman, P., and R. M. Zinkernagel. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:482-485. (Pubitemid 28373959)
14. Nolan, T., et al. 2010. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. JAMA 303:37-46.
15. Palmer, D. F., M. T. Coman, W. R. Dowdle, and G. C. Schild. 1975. Advanced laboratory techniques for influenza diagnosis. Immunol. Ser. 6:51-52.
16. Pascua, P. N., et al. 2009. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One 4:e8431.
17. Plennevaux, E., E. Sheldon, M. Blatter, M. K. Reeves-Hoche, and M. Denis. 2010. Immune response after a single vaccination against 2009 influenza A H1N1 in U.S.A.: A preliminary report of two randomised controlled phase 2 trials. Lancet 375:41-48.
18. Skowronski, D. M., et al. 2010. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada. PLoS Med. 7:e1000258.
19. Song, M. S., et al. 2009. Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. Vaccine 27:3145-3152.
20. WHO. 2009. New influenza A (H1N1) virus: Global epidemiological situation, June 2009. Wkly. Epidemiol. Rec. 84:249-257.
21. Zhu, F. C., et al. 2009. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 361:2414-2423.